- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
...And the hits just keep coming!
Despite the DOJ memo and our best efforts the federal government continues to engage innovative tactics to continue their campaign of interference with state medical marijuana laws. The latest tactic is to use an antiquated tax code to prohibit medical marijuana dispensing facilities from taking IRS deductions and credits attributed to amounts paid or incurred during the taxable year. ASA has confirmed that several medical cannabis collectives in California are now being (and have in the past been) targeted by this very law under the guise of federal tax audits. These “audits” seem to be unfairly applied, especially as they appear to target the largest collectives serving the greatest percentage of the population.
For the patients who rely on the access to medicine these collectives provide, enforcement of this provision could result in a number of unanticipated consequences. Without doubt, collectives will be forced to raise the cost of medicine and services in order to compensate for the loss of a deduction/credit. It’s possible that some collectives may simply stop filing federal tax returns, which may jeopardize the integrity of the collective and put patients in harm’s way. And, in the worst case, collectives will simply shut their doors, forcing what are otherwise well regulated facilities back to the underground.
To combat this issue ASA has enlisted the leadership of Congressman Pete Stark (D-CA), known as one of the nation's foremost advocates of tax reform. Mr. Stark has championed a “Request for a Revenue Ruling on Allowing Legal Marijuana Dispensaries to Take Trade or Business Deductions.” Mr. Stark and a handful of Congressional colleagues who also serve as senior members of the relevant oversight committees including Ways & Means, Joint Taxation, Banking, and Judiciary have cosigned a letter requesting that the IRS issue a revenue ruling - or similar pronouncement upon which all taxpayers may rely - concerning deductions for medical marijuana dispensaries.
The Revenue Request represents an initial step toward a final solution and ASA will continue our dialogue with Congress and Administration officials about this issue. These ongoing and indirect tactics underscore a need for Congress to provide a solution to the growing divide between state and federal laws concerning the use of marijuana for medical purposes. In the meantime, PLEASE visit the following webpages and offer these allies your personal thanks and sincere appreciation for their leadership on this important issue.Congressman Pete Stark (D-CA/13) Congressman Sam Farr (D-CA/17) Congressman Raul Grijalva (D-AZ/7) Congressman Barney Frank (D-MA/4) Congresswoman Linda Sanchez (D-CA/39) Congressman Jared Polis (D-CO/2)